Bodo, Juraj <br/><br/>
HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells.  [electronic resource] 

 -  Apoptosis : an international journal on programmed cell death  Sep 2011 
 - 914-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-675X 
<br/><br/><label>Standard No.: </label>10.1007/s10495-011-0617-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Caspase 3--metabolism<br/>Caspase 7--metabolism<br/>Cell Cycle Checkpoints<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Drug Synergism<br/>Fluorescent Antibody Technique<br/>Histone Deacetylase Inhibitors--administration & dosage<br/>Humans<br/>Hydroxamic Acids--administration & dosage<br/>Indoles--administration & dosage<br/>Lymphoma--drug therapy<br/>Sulfides--pharmacology<br/>Tumor Suppressor Protein p53--metabolism<br/>Valproic Acid--administration & dosage<br/>Vorinostat